wˈʌn ɹˈiːsənt stˈʌdi ʃˈoʊd ðæt dʒˈɛmɪflˌɑːksɐsˌɪn pəzˈɛs ˈæntaɪmˌɛɾəstˈæɾɪk æktˈɪvᵻɾiz ɐɡˈɛnst bɹˈɛst kˈænsɚɹ ɪn vˈɪtɹoʊ ænd ɪn vˈiːvoʊ ɪn mˈaɪs.
One recent study showed that Gemifloxacin possess anti-metastatic activities against breast cancer in vitro and in vivo (in mice).